Hoth Therapeutics, a biopharmaceutical company, has announced its intention to purchase $1 million worth of Bitcoin. This decision was approved by its Board of Directors and is aimed at strengthening the company's treasury reserve.
The announcement has sparked significant discussions globally, highlighting the growing trend of non-traditional companies investing in cryptocurrency as a strategy to diversify their financial portfolios.
